×

West Pharmaceutical Services Net Profit Margin 2010-2024 | WST

Current and historical net profit margin for West Pharmaceutical Services (WST) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. West Pharmaceutical Services net profit margin for the three months ending December 31, 2024 was .
West Pharmaceutical Services Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $2.89B $0.49B 17.01%
2024-09-30 $2.88B $0.50B 17.35%
2024-06-30 $2.88B $0.52B 18.22%
2024-03-31 $2.93B $0.57B 19.40%
2023-12-31 $2.95B $0.59B 20.10%
2023-09-30 $2.93B $0.56B 19.10%
2023-06-30 $2.87B $0.52B 18.10%
2023-03-31 $2.88B $0.55B 19.17%
2022-12-31 $2.89B $0.59B 20.33%
2022-09-30 $2.91B $0.63B 21.73%
2022-06-30 $2.93B $0.69B 23.46%
2022-03-31 $2.88B $0.69B 23.77%
2021-12-31 $2.83B $0.66B 23.37%
2021-09-30 $2.68B $0.61B 22.82%
2021-06-30 $2.52B $0.52B 20.53%
2021-03-31 $2.33B $0.42B 18.14%
2020-12-31 $2.15B $0.35B 16.07%
2020-09-30 $2.04B $0.31B 15.26%
2020-06-30 $1.95B $0.29B 14.65%
2020-03-31 $1.89B $0.26B 13.76%
2019-12-31 $1.84B $0.24B 13.09%
2019-09-30 $1.79B $0.23B 12.78%
2019-06-30 $1.77B $0.23B 12.90%
2019-03-31 $1.75B $0.22B 12.49%
2018-12-31 $1.72B $0.21B 12.05%
2018-09-30 $1.71B $0.16B 9.05%
2018-06-30 $1.68B $0.15B 9.00%
2018-03-31 $1.63B $0.13B 8.23%
2017-12-31 $1.60B $0.15B 9.44%
2017-09-30 $1.57B $0.19B 12.13%
2017-06-30 $1.55B $0.18B 11.46%
2017-03-31 $1.54B $0.18B 11.92%
2016-12-31 $1.51B $0.14B 9.54%
2016-09-30 $1.49B $0.14B 9.28%
2016-06-30 $1.46B $0.10B 7.01%
2016-03-31 $1.43B $0.09B 5.96%
2015-12-31 $1.40B $0.10B 6.85%
2015-09-30 $1.39B $0.09B 6.76%
2015-06-30 $1.40B $0.12B 8.77%
2015-03-31 $1.41B $0.13B 9.43%
2014-12-31 $1.42B $0.13B 8.93%
2014-09-30 $1.42B $0.12B 8.48%
2014-06-30 $1.40B $0.12B 8.28%
2014-03-31 $1.38B $0.11B 7.84%
2013-12-31 $1.37B $0.11B 8.25%
2013-09-30 $1.35B $0.11B 8.16%
2013-06-30 $1.31B $0.10B 7.48%
2013-03-31 $1.29B $0.08B 6.51%
2012-12-31 $1.27B $0.08B 6.39%
2012-09-30 $1.24B $0.08B 6.37%
2012-06-30 $1.23B $0.08B 6.59%
2012-03-31 $1.21B $0.09B 7.01%
2011-12-31 $1.19B $0.08B 6.38%
2011-09-30 $1.17B $0.06B 5.37%
2011-06-30 $1.15B $0.06B 5.56%
2011-03-31 $1.13B $0.07B 5.87%
2010-12-31 $1.11B $0.07B 5.97%
2010-09-30 $1.12B $0.08B 7.14%
2010-06-30 $1.11B $0.08B 7.12%
2010-03-31 $1.09B $0.08B 7.08%
2009-12-31 $1.06B $0.07B 6.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.185B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $84.343B 23.08
Becton Dickinson (BDX) United States $65.771B 16.47
Cardinal Health (CAH) United States $33.281B 17.82
Labcorp (LH) United States $19.480B 15.97
Straumann Holding AG (SAUHY) Switzerland $19.198B 0.00
Cooper (COO) United States $16.868B 22.37
Align Technology (ALGN) United States $11.630B 22.53
Henry Schein (HSIC) United States $8.505B 14.45
Merit Medical Systems (MMSI) United States $6.219B 30.38
DENTSPLY SIRONA (XRAY) United States $2.973B 8.95
Patterson (PDCO) United States $2.764B 15.94
CONMED (CNMD) United States $1.867B 14.52
STAAR Surgical (STAA) United States $0.870B 0.00
Lifevantage (LFVN) United States $0.183B 20.25
Pro-Dex (PDEX) United States $0.162B 24.67